Literature DB >> 16143883

Characteristics of symptomatic GERD in Japanese patients based on 24-h pH monitoring.

Nobuo Omura1, Hideyuki Kashiwagi, Fumiaki Yano, Kazuto Tsuboi, Katsuhiko Yanaga.   

Abstract

BACKGROUND: We assessed the characteristics of symptomatic gastroesophageal reflux disease (sGERD), defined as the presence of symptoms, but no endoscopic findings of reflux esophagitis, in Japanese.
METHODS: Sixty-three patients were diagnosed with sGERD, and underwent 24-h esophagogastric pH monitoring (32 men; mean age, 50.5 years). Patients were classified into the following three groups : reflux group (group R), minor reflux group (group MR), and a no-reflux group (group N) by the percentage of time at pH below 4 (group R, 4.0% or more; group MR, 2.0%-3.9%; group N, 0-1.9%). Hiatal hernia was assessed based on the Anatomy-Function-Pathology (AFP) classification, and the shape of the cardia was assessed based on valve factors (V0-V3).
RESULTS: There were 13 patients (21%) in group R, 17 (27%) in group MR, and 33 (52%) in group N. Hiatal hernia was present in 11 patients (85%) in group R, 14 (82%) in group MR, and 22 (67%) in group N. Patients grouped according to presence of V2/V3 (chalasia) accounted for 100% of those in group R, 71% of those in group MR and 70% of those in group N. Hiatal hernia was present in 10 (91%), 10 (83%), and 6 patients (86%) who had 50 or more episodes of esophageal acid reflux per day in group R, group MR, and group N, respectively.
CONCLUSIONS: Reflux (percentage of time below pH 4, 4%) was seen in only about 20% of the patients with sGERD, and this percentage of patients with reflux was lower compared to the data reported from the United States and Europe. The percentage of patients who had a hiatal hernia or chalasia was high in all these groups, and this seemed to be a characteristic cause of sGERD in Japanese.

Entities:  

Mesh:

Year:  2005        PMID: 16143883     DOI: 10.1007/s00535-005-1629-5

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  15 in total

1.  Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group.

Authors:  R Carlsson; J Dent; R Watts; S Riley; R Sheikh; J Hatlebakk; K Haug; G de Groot; A van Oudvorst; A Dalväg; O Junghard; I Wiklund
Journal:  Eur J Gastroenterol Hepatol       Date:  1998-02       Impact factor: 2.566

2.  Twenty-four-hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux.

Authors:  L F Johnson; T R Demeester
Journal:  Am J Gastroenterol       Date:  1974-10       Impact factor: 10.864

3.  Acid, nonacid, and gas reflux in patients with gastroesophageal reflux disease during ambulatory 24-hour pH-impedance recordings.

Authors:  D Sifrim; R Holloway; J Silny; Z Xin; J Tack; A Lerut; J Janssens
Journal:  Gastroenterology       Date:  2001-06       Impact factor: 22.682

4.  Barrett's esophagus: prevalence and size of hiatal hernia.

Authors:  A J Cameron
Journal:  Am J Gastroenterol       Date:  1999-08       Impact factor: 10.864

Review 5.  Epidemiology and pathophysiology of symptomatic gastroesophageal reflux disease.

Authors:  Ronnie Fass
Journal:  Am J Gastroenterol       Date:  2003-03       Impact factor: 10.864

Review 6.  Diagnosis of symptomatic gastroesophageal reflux disease.

Authors:  Peter J Kahrilas
Journal:  Am J Gastroenterol       Date:  2003-03       Impact factor: 10.864

Review 7.  Endoscopy-negative reflux disease: concepts and clinical practice.

Authors:  William D Chey
Journal:  Am J Med       Date:  2004-09-06       Impact factor: 4.965

8.  Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response.

Authors:  T Lind; T Havelund; R Carlsson; O Anker-Hansen; H Glise; H Hernqvist; O Junghard; K Lauritsen; L Lundell; S A Pedersen; A Stubberöd
Journal:  Scand J Gastroenterol       Date:  1997-10       Impact factor: 2.423

9.  Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice.

Authors:  T L Venables; R D Newland; A C Patel; J Hole; C Wilcock; M L Turbitt
Journal:  Scand J Gastroenterol       Date:  1997-10       Impact factor: 2.423

10.  Omeprazole as a diagnostic tool in gastroesophageal reflux disease.

Authors:  B E Schenk; E J Kuipers; E C Klinkenberg-Knol; H P Festen; E H Jansen; H A Tuynman; M Schrijver; L A Dieleman; S G Meuwissen
Journal:  Am J Gastroenterol       Date:  1997-11       Impact factor: 10.864

View more
  2 in total

1.  Gastroesophageal flap valve is associated with gastroesophageal and gastropharyngeal reflux.

Authors:  Gwang Ha Kim; Dae Hwan Kang; Geun Am Song; Tae Oh Kim; Jeong Heo; Mong Cho; Jin Seon Kim; Byung Joo Lee; Soo Geun Wang
Journal:  J Gastroenterol       Date:  2006-07       Impact factor: 7.527

2.  Relationship of the frequency scale for symptoms of gastroesophageal reflux disease with endoscopic findings of cardiac sphincter morphology.

Authors:  Kazuto Tsuboi; Nobuo Omura; Fumiaki Yano; Hideyuki Kashiwagi; Katsuhiko Yanaga
Journal:  J Gastroenterol       Date:  2008-10-29       Impact factor: 7.527

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.